| Financial Year |
March 31 2023 |
| Monetary Funds |
25,105,765.98 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
9,553,372.20 |
| Accounts Receivable |
96,383,189.24 |
| Advances to Suppliers |
8,454,411.95 |
| Other Receivables |
8,814,885.87 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
303,299,253.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,181,890.37 |
| Total Current Assets |
458,792,769.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
338,074,457.45 |
| Under-construction Projects |
20,675,537.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
89,519,111.78 |
| R&D expenses |
-- |
| Goodwill |
89,365,605.58 |
| Long-Term Deferred and Prepaid Expenses |
201,961.69 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
542,386,628.33 |
| Total Assets |
1,001,179,397.43 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
43,011,269.47 |
| Accounts Received In Advance |
3,528,157.58 |
| Employee Compensation Payable |
16,001,608.05 |
| Taxes Payable |
3,066,576.73 |
| Interest Payable |
945,213.44 |
| Dividend Payable |
1,104,960.50 |
| Other payables |
264,933,959.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,192,750.08 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
349,792,616.16 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
299,457,652.36 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,831,380.53 |
| Other Non-Current Liabilities |
7,917,213.64 |
| Sub-Total of Non-Current Liabilities |
322,384,315.22 |
| Total Liabilities |
672,176,931.38 |
| Paid-In Capital(Or Share Stock) |
129,800,000.00 |
| Capital Surplus |
467,273,395.90 |
| Surplus Reserve |
13,786,380.32 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-459,321,389.21 |
| Minority Stockholder's Interest |
176,251,972.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
152,750,493.37 |
| Owner's Equity（Stockholder's Equity） |
329,002,466.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,001,179,397.43 |
